Thứ Năm, 27 tháng 4, 2017

Waching daily Apr 27 2017

Global Market Cap Hits $50 Trillion For The First Time Ever As All Eyes Turn To Trump

Tax Plan

by Tyler Durden

After two days of back to back triple digit gains in the Dow for the first time since

the election, overnight the torrid rally has faded, with European shares and U.S. stock

futures little changed ahead of Trump's big unveil of his much anticipated tax cut plan

as investors seek new impetus for a flagging relief rally. And, if as some traders expect,

the rally is likely to be reignited no matter what Trump announces today (although a less

hyperbolic plan may in fact be more favorable for risk, as it makes Trump's plan more likely

instead of being shot down by Congress).

Despite the tapering of euphoria, world stocks hit another all time high on the back of strong

earnings and the realization that whatever Trump says, the S&P - less than 1% from all

time highs - will likely hit a new record. the MSCI world equity index, which tracks

shares in 46 countries, was up 0.1% to a fresh record high. It is up nearly 2% this week

and 8.35% since the start of the year. As Bloomberg's David Ingles charts, the market

cap of all stocks in the index, and thus the world, has just surpassed $50 trillion for

the first time ever.

"On top of (the French election result) we have had a very decent set of corporate earnings

in the U.S. and that helped push the market further along the same direction," said Investec

economist Philip Shaw. "I am unsure how further along we really are on the tax cutting agenda,

but it is certainly not doing market sentiment any harm," he added.

Further details on President Trump's tax cutting plans are expected to be announced later on

Wednesday, potentially reviving reflation bets. The threat of a U.S. government shutdown

this weekend also receded after Trump backed away from demanding Congress include funding

for his planned border wall with Mexico in a spending bill.

The dollar rebounded modestly for a second day after plunging in the past week to lows

not seen since November, gaining against most group-of-10 currencies even as the WTI slide

continues, with crude languishing below $50 a barrel after a report on U.S. supplies.

European stocks halted a five-day advance that had taken them to the highest since 2015

as earnings painted a mixed picture on growth.

According to Bloomberg, investors are waiting to see if Trump�s conciliatory tone on the

border wall could help avert a government shutdown even as most members of the Congress

are in the dark about the $1.1 trillion spending bill. Policy reviews by the Japanese and European

Central Bank may also set the tone for rest of the week.

European shares pulled back slightly from 20-month highs as some disappointing corporate

results weighed on the market but Asian stocks powered ahead. The Stoxx Europe 600 Index

was little changed, after a five-day rally to the highest since August 2015.

Japan�s Topix index rose 1.2 percent, climbing for a fifth straight day for the longest winning

streak this year. Futures on the S&P 500 Index were flat after the underlying gauge climbed

0.6 percent on Tuesday, to within 10 points of its closing record.

The early FX price action this morning has been in the EUR, as the market has faded the

story out late yesterday that the ECB are considering signalling a tweak in their monetary

policy stance in the wake of the Macron first round victory at the weekend. This sounds

premature to say the least, and alongside this, we have seen Draghi and Co curbing some

of the hawkish sentiment in response to their last meeting. The recovery EU wide is a little

better than fragile, but as the Fed have been struggling to do in their communication to

the market, the ECB now face a similar task.

The slew of positive news pushed the Nasdaq composite to a record high on Tuesday while

the Dow and S&P 500 brushed against recent peaks.

Against a strengthening dollar, the euro held on to the bulk of the gains made earlier this

week; it fell 0.13 percent to $1.0911, but is still up 1.72 percent from Friday's close.

U.S. Treasury yields, meanwhile, rose above 2.30 percent for the first time in two weeks.

"U.S. bond yields have broken higher without the support of commodity prices which is one

of the clearest signs that the Trump trade is back," Morgan Stanley analysts said in

a note. Euro zone government bond yields nudged up ahead of Trump's keenly anticipated tax

announcement.

Oil prices resumed their downward trend on Wednesday as data showed a rise in U.S. crude

inventories and record supplies in the rest of the world cast doubt on OPEC's ability

to cut supplies and tighten the market.

Economic data include revision of retail sales. Procter & Gamble, PepsiCo are among companies

scheduled to publish results. Alphabet, Microsoft, Amazon.com, Twitter, Intel, Barclays, Bayer

AG and Total SA are among major companies releasing results later this week. The Bank

of Japan is widely expected to keep the settings on its monetary easing program unchanged at

the end of a two-day policy meeting on Thursday. Though inflation remains well below the central

bank�s 2 percent target, it�s ticking up. The ECB sets monetary policy later that

same day. With officials indicating little chance of a policy change, the focus will

be on any signals from President Mario Draghi that the central bank is debating an exit

from its extraordinary stimulus.

Market Snapshot

S&P 500 futures down less than 0.1% to 2,384.00 STOXX Europe 600 unchanged at 386.90

MXAP up 0.5% to 149.55 MXAPJ up 0.3% to 487.86

Nikkei up 1.1% to 19,289.43 Topix up 1.2% to 1,537.41

Hang Seng Index up 0.5% to 24,578.43 Shanghai Composite up 0.2% to 3,140.85

Sensex up 0.7% to 30,149.50 Australia S&P/ASX 200 up 0.7% to 5,912.04

Kospi up 0.5% to 2,207.84 German 10Y yield fell 1.0 bps to 0.368%

Euro down 0.2% to 1.0910 per US$ Brent Futures down 0.04% to $52.08/bbl

Italian 10Y yield rose 8.4 bps to 1.972% Spanish 10Y yield rose 1.1 bps to 1.686%

Gold spot up 0.1% to $1,265.84 U.S. Dollar Index up 0.2% to 98.98

Top Headline News from Bloomberg

President Donald Trump�s expected call to slash the corporate tax rate to 15 percent

-- a number that many economists say would boost the deficit so much that the cut would

be short-lived -- may be less about policy and more about deal-making

The roll-out of legislation this week that would rip up much of the Dodd-Frank Act marks

a pivotal moment for Republicans� efforts to overhaul post-crisis financial rules

Credit Suisse Chief Executive Officer Tidjane Thiam is bowing to investor pressure to keep

the bank�s biggest profit generator and instead will bolster capital by selling stock

in a rights offer KKR & Co. offered to buy a controlling stake

in Hitachi Kokusai Electric Inc., the chip system-making unit of Hitachi Ltd., in a bid

that values the target at $2.3 billion BHP Billiton Ltd. said it may resurrect the

sale of its under-performing Fayetteville shale gas assets in Arkansas a little more

than two weeks after billionaire Paul Singer proposed spinning off the mining company�s

U.S. petroleum division China Southern Airlines Co. said it plans

to buy 20 widebody aircraft from Airbus SE in a deal worth about $6 billion, according

to a filing to the Hong Kong stock exchange Wednesday

KKR to Acquire Hitachi Kokusai in Deal Valued at $2.3b

IQiyi, Netflix Reach Content Cooperation Agreement Uber to Question Alphabet�s Larry Page in

Robocar Case Bayer-Monsanto Deal Needs EU Scrutiny, NRW

Minister Tells RP Shanghai to Develop �Water Town� Next

to Disneyland, Zone Says Asia equity markets maintained the positive

momentum from their counterparts in US, where the DJIA outperformed on strong earnings and

the NASDAQ Comp. closed over 6,000 for the first time ever. ASX 200 (+0.8%) gained on

return from holiday, while Nikkei 225 (+1.1%) benefitted after the JPY weakened against

its major counterparts. The Hang Seng (+0.3%) and Shanghai Comp. (+0.2%) also conformed

to the upside after the PBoC continued its liquidity injections. Finally, 10yr JGBs were

lower with demand dampened amid the broad-based heightened risk appetite and as the BoJ kick-started

its 2-day policy meeting in which the bank is widely expected to remain on hold, while

there was also notable underperformance observed in the super long end.

PBoC injected CNY 40bIn in 7-day reverse repos, CNY 20bIn in 14-day reverse repos and CNY

20bIn in 28-day reverse repos.

Top Asian News

China�s Homemade Aircraft Carrier Is Second in Xi�s Fleet

China Merchants Seeks to Overtake UBS in Asia With Offshore Push

China Market Strains Worsen as AAA Rated Vanke Scraps Bond Sale

ICRA Sees FY18 Foreign Flows Into Indian Debt Capped at $5- $10b

China Eastern Said in Cargo Stake Sale Talks With Private Firms

Huarong Investment Risks in Spotlight After Glaucus Report

Hyundai Motor Counts on SUV, Genesis Brand to Revive Profits

Korean Peninsula on Brink of War Provoked From Outside: Russia

European bourses fail to find any firm direction with equities trading somewhat mixed yet again.

Earning updates are yet again at the forefront of investors' minds, with Credit Suisse outperforming

in the SMI this morning after announcing profit rose above analyst estimates, additionally

the Swiss bank noted that they will raise USD 4bIn in a rights issues. Elsewhere, luxury

names have been lifted after Kering stated that their organic growth were significantly

ahead of expectations. Credit markets have found some support following yesterday's risk

sentiment as the bund has seen a slow grind higher since the cash open, benefiting from

month-end extension buying needs.

Top European News

Santander�s Brazil Patience Pays off as Rebound Lifts Profit

Kering Shares Surge After Gucci�s Strongest Growth in 20 Years

Standard Chartered Profit Soars as Bank Overhaul Gains Traction

Daimler Raises Earnings Forecast as Spending Pressure Mounts

HSBC, RBS Saudi Ventures in Talks to Form $78 Billion Lender

BHP Considers U.S. Shale Asset Sale After Activist Call

Handelsbanken�s Capital Supremacy Fails to Charm Shareholders

Telia Sees Lower Uzbek Fine of $1 Billion as Sales Top Views

SEB Sees Riksbank Move After �Shock� Sweden Manufacturing Data

De Benedetti Bets on Media as Italy Business Clans Look to Sell

In currencies, the Bloomberg Dollar Spot Index increased 0.2%, climbing for a second day

after a 0.5 percent drop on Monday. The yen slipped 0.1 percent to 111.24 per dollar,

after dropping 1.2 percent on Tuesday. The euro lost 0.2 percent to $1.0903, after four

straight days of gains. The early price action this morning has been in the EUR, as the market

has faded the story out late yesterday that the ECB are considering signalling a tweak

in their monetary policy stance in the wake of the Macron first round victory at the weekend.

This sounds premature to say the least, and alongside this, we have seen Draghi and Co

curbing some of the hawkish sentiment in response to their last meeting. The recovery EU wide

is a little better than fragile, but as the Fed have been struggling to do in their communication

to the market, the ECB now face a similar task. So the 1.0950 test was inevitable given

the headline driven market, but EUR/USD has since tempered this with a move back to 1.0900,

while EUR/GBP � traditionally bid into month end � is also restrained through 0.8500

� but largely down to Cable resilience ahead of 1.2750, but now seemingly 1.2800 (1.2805

the low this morning). For EUR/USD, 1.0850-30 looks strong in the meantime. USD/JPY has

also slipped back a little, and as we noted yesterday, sellers aplenty in the 111.00-112.00

area. We suspect a large chunk of the upside is down to the hopes and expectations of credible

tax plans to be 'outlined' in an announcement later today, so the risk here is that the

market is (again?) disappointed. EUR/JPY has also relented given the above move, and after

failing to touch on 122.00, we are back in the lower 121.00's.

In commodities, gold struggled with reclaiming USD1270 yesterday, and we have since slipped

back into the mid USD1260's as the recovery in the USD index allied with a modest recovery

in risk assets put further pressure on precious metals. Silver has also given up ground, and

has dipped into the USD17.50's. Oil prices back in focus after we slipped back under

USD50.00 in WTI, resuming its decline and losing 0.2% to $49.45 per barrel, after halting

a six-day selloff on Tuesday. . OPEC talks now key as Oil bulls need further encouragement

on an extension to the output cuts. The major producers all seem broadly open to the idea,

most of all Saudi Arabia as ongoing comments suggest. Key EIA report today with speculation

inventory will contract. Base metals all following the risk mood, with ranges tight ahead of

Trump announcement later today. Copper buoyed but struggles at USD2.60.

It�s a very quiet day ahead in terms of data. Over in Europe French consumer confidence

for April is the only number of note and is expected to be unchanged at 100, and there�s

nothing of note to watch in the US. However earnings season continues with Proctor & Gamble

and Boeing due to report today among other names. Away from data, we will see UK PM Theresa

May host EC President Juncker and EU�s Brexit negotiator Michal Barnier today

US Event Calendar

DB's Jim Reid concludes the overnight wrap

So on day 97 of his Presidency, today is all about Mr Trump's tax plans of which the eventual

success (or lack of it) will likely define the economic landscape of his administration.

The WSJ last night reaffirmed that Mr Trump wants to slash corporate tax including on

pass through businesses. He is also planning a tax break for child care expenses. There

was also talk of a territorial tax for companies where they would pay little or no tax on future

foreign earnings. Bloomberg also report that a repatriation tax of 10% is planned on the

estimated $2.6tn of stockpiled offshore earnings. Anyway whatever we hear today it will still

have to go through legislative approval and there will a lot of talk about how tough that

will be if it's not revenue neutral.

Staying with US politics there were signs yesterday that a US government shutdown may

end up being averted as President Trump showed signs of easing up on his demands for the

immediate funding of the border wall. So far the spending plan needed to keep agencies

running till September has been kept quiet ahead of this Friday�s deadline, but Trump�s

willingness to push back funding the wall to later this year could be a sign that he

would be ready to sign the spending bill.

Ahead of the big day in Washington, sentiment across global markets remained positive yesterday

following the relief rally on Monday. European equities ticked up on the day (STOXX +0.2%)

while the Eurozone Banks index gained by +0.6%. The DAX and CAC posted small gains of +0.1%

and +0.2%. US equity markets maintained momentum with the S&P gaining +0.6%, led by Materials

(+1.4%) and Financials (+1.2%). Strong bluechip earnings helping. The NASDAQ also hit a new

all time high, breaking the 6,000 mark for the first time after gaining +0.7% on the

day. Interestingly this was 17 years after first hitting 5,000 although without checking

one wonders how many constituents were in the index back then that are still there today.

We note that having taken 17 years to fill in this last 1,000 point gap, it only took

49 days to move from 4,000 to 5,000 back in 2000. Another stat is that the index is now

up around 4.7 times from its lows in March 2009. Impressive and all these stats are a

reminder that timing is everything in investing!

Elsewhere risk-on continued in credit. In Europe we saw Main and Crossover spread tighten

by -2bps and -8bps respectively, while Senior and Sub financials spreads tightened by -5bps

and -11bps on the day. Over in the US we saw similar moves tighter as CDX IG and HY tightened

by -2bps and -7bps respectively. We saw a broad based sell off in government bond markets

with yields rising across all maturities for US treasuries (2Y: +4bps; 10Y: +6bps) and

Bunds (2Y: +2bps; 10Y: +5bps) . Yields for 10Y OATs and BTPs yields also rose on the

day by +7bps and +9bps respectively, with the 10Y OAT-Bund spread widening by +2bps.

In currency markets we saw the dollar (-0.3%) weaken for the second day in a row while the

Euro gained +1.0%. Sterling also gained +0.5% to reach its highest level this year. Moves

over in commodity markets were fairly muted at both ends of the risk spectrum, with WTI

and Gold mostly flat. The Asian session is also relatively quiet with the positive mood

of the last few days continuing. The Nikkei is 0.7% higher as the BoJ start their 2-day

meeting, the Hang Seng +0.6% and the Shanghai Comp +0.35%. Gold, the Dollar, Oil and Treasuries

haven't moved much in the overnight session.

Looking now at some of the data out yesterday. In Europe, the ECB Q1 Bank Lending Survey

was broadly positive as credit standards loosened across all three major categories. Loans to

enterprises dipped back into easing territory (-2%) after having ticked up by +5% in Q4

2016. The net easing was roughly in line with the expected change in standards as reported

in the previous survey, and banks now expect a net tightening of lending standards for

enterprises in Q2 (2%). Standards for consumer credit and lending to households also loosened

in Q1 (-7% and -5% respectively). Despite loose lending conditions credit demand growth

from enterprises is slowing down: net 6% of banks reported an increase in loan demand

from enterprises in Q1 but this was well below the 11% that expected an increase (as reported

in the previous survey) and also less than the 18% reporting an increase in loan demand

in Q4 2016. Banks however expect net loan demand from enterprises to accelerate in Q2

2017 (12%).

Elsewhere in Europe we also got French manufacturing confidence numbers for April that rose more

than expected (108 vs. 105 expected; 104 previous) while business confidence was flat on the

month (104) as expected. In the UK the PSNB numbers (including banks) for March were reported

well above expectations at GBP 4.4bn (vs. 1.5bn expected).

Over in the US we saw a large number of housing market indicators which were mostly positive.

The FHFA house price index rose by +0.8% mom in February (vs. 0.4% expected) while new

home sales unexpectedly rose to 621k (vs. 584k expected; 592k previous). In terms of

softer data, the consumer board consumer confidence indicator for April fell more than expected

to 120.3 (vs. 122.5 expected; 125.6 previous). The Richmond Fed manufacturing survey also

fell on the month but less so than expected (20 vs. 16 expected; 22 previous). It�s

a very quiet day ahead in terms of data. Over in Europe French consumer confidence for April

is the only number of note and is expected to be unchanged at 100, and there�s nothing

of note to watch in the US. However earnings season continues with Proctor & Gamble and

Boeing due to report today among other names. Away from data, we will see UK PM Theresa

May host EC President Juncker and EU�s Brexit negotiator Michal Barnier today.

For more infomation >> Global Market Cap Hits $50 Trillion For The First Time Ever As All Eyes Turn To Trump Tax Plan - Duration: 24:42.

-------------------------------------------

First of Its Kind Study Finds Cannabis May Be a Miracle Treatmen - Duration: 6:05.

First of Its Kind Study Finds Cannabis May Be a �Miracle� Treatment for Autistic

Kids

Autism could now be added to the lengthy and perpetually-expanding list of afflictions

and symptoms treatable with the one product of nature shamefully prohibited by the federal

government � the �miracle� palliative, cannabis

One in every 68 children in the United States is now affected by autism, and the number

of kids coping with the developmental disorder has been increasing at an explosive rate in

recent years.

With onset most common during infancy and early childhood, autism can impact social

and communication skills and may cause repetitive or compulsive behaviors, among other manifestations.

Now, fresh evidence again frowns upon U.S. federal prohibition of cannabis � listed

as a Schedule I dangerous substance of no potential medical use, alongside heroin � which

could be depriving ailing children the chance for treatment, and hope for a better-adjusted

future.

In contrast to its staunch U.S. ally, Israel has approached the cannabis plant as the medicinal

healer it has more than proven to be � medical marijuana was first approved in Israel decades

ago, in 1992, making it one of the first in the world to do so.

As USA Today notes, in a recent article titled, Marijuana may be a miracle treatment for children

with autism, Israel and just two other countries � Canada and the Netherlands � have government-sponsored

medical marijuana programs available to citizens.

Because of the notorious, if not nefarious, American war on drugs irresponsibly focuses

on the cannabis plant as a dangerous substance sans redeeming medical value, research here

lags exponentially behind other nations � unnecessary red tape, regulations, laws, and restrictions

make procuring clearance for scientific study a somewhat odious hurdle.

To wit, the Food and Drug Administration � which, incidentally, oversees the drug warriors of

the DEA � has thus far only approved two antipsychotic pharmaceuticals for the treatment

of symptoms of autism.

Both of those come replete with a host of serious and untenable side effects � making

the choice to treat a difficult one, at best.

Israeli researchers, unbound by the absurdities of the drug war, began a new study in January

at the Shaare Zedek Medical Center in Jerusalem, comprised of 120 children ranging in age from

five to 29 years, who have been diagnosed with mild to severe autism.

Study participants are given one of two cannabis oil treatments or a placebo, drops of which

can be mixed into a meal � none contain high levels of THC, the ingredient which gives

users a �high.�

�Adi Aran, the pediatric neurologist leading the study, said nearly all the participants

previously took antipsychotics and nearly half responded negatively.

Yael desperately pushed Aran and other doctors to prescribe cannabis oil after a news report

aired about a mother who illegally obtained it for her autistic son and said it was the

only thing that helped him,� USA Today reports.

Myriad scientific studies and innumerable anecdotal cases have proven cannabis to treat

everything from PTSD to ADHD, various cancers to the painful pressure of glaucoma � but

the plant�s miraculous quality has been most apparent in treating severe seizures

of childhood epilepsy.

Now, it appears, cannabis � specifically, the non-psychoactive compound, cannabidiol

or CBD � may offer improved quality of life for children with autism, and the families

providing their care.

�Many parents were asking for cannabis for their kids,� Aran told USA Today.

�First I said, �No, there�s no data to support cannabis for autism, so we can�t

give it to you.��

Doubt quickly lifted, however, after multiple studies championed cannabis in the treatment

of childhood epilepsy and in reducing the severity of symptoms of autism.

Aran points out 30 percent of children with autism are also afflicted with epilepsy.

In an observational study, the doctor found 70 patients with autism experienced positive

results from cannabis � so the clinical trial was launched for in-depth study.

Where Israel provides hope for families of children with various ailments with government-sponsored

cannabis care, parents in the United States are forced to grapple with a patchwork of

laws and regulations.

Packing up a house of belongings to flee draconian marijuana laws for life-saving cannabis treatment

has become commonplace to the point such families are now deemed, in all seriousness, medical

refugees.

As long as cannabis prohibition remains in effect � an overwhelming likelihood, given

the profiteering possible at every level of the system, from police departments to courts

to for-profit prisons, and so on � children and adults will needlessly suffer without

the healing powers of a substance that couldn�t get anyone high.

One-hundred-ten clinical trials of cannabis are currently underway in Israel � and although

there may be many in the U.S., research primarily focuses on the treatment of addiction and

related issues.

Should cannabis, specifically, CBD oil, prove its mettle in treating the symptoms of autism

in children, it would behoove U.S. bureaucrats and drug warriors to pay attention and save

lives � rather than standing tough on an anachronistic and harmful national policy

Không có nhận xét nào:

Đăng nhận xét